Dr. Huren Sivaraj | Source | CEO and Co-Founder at Oncoshot

Dr. Huren Sivaraj, CEO and Co-founder of Oncoshot, is a leader in Singapore’s AI-driven healthcare revolution. As a medical oncologist specializing in breast cancer, Dr. Sivaraj combines his clinical expertise with cutting-edge technology to address critical gaps in cancer treatment. Under his visionary leadership, Oncoshot has emerged as a pioneer in utilizing AI and Large Language Models (LLMs) to enhance cancer data extraction and management, driving clinical trial innovation.

Oncoshot’s platform enables data-driven collaboration between clinicians, researchers, and pharmaceutical companies, optimizing clinical trial matching and accelerating the development of life-saving therapies. Partnered across 7 countries, Oncoshot’s AI capabilities compute data from more than 120,000 living cancer patients, allowing physicians to access critical information on matching trials in real-time. This transformative approach streamlines the clinical trial process, improving the pace of therapeutic development and access.

Dr. Sivaraj’s leadership has fostered key partnerships with government bodies and healthcare institutions, furthering Singapore’s ambition to be a global hub for AI-powered healthcare. His dedication to driving innovation has significantly advanced both cancer research and AI integration, setting new benchmarks for how AI can revolutionize patient care worldwide.